The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The interaction of p53 with replication protein A mediates suppression of homologous recombination
Abstract
The tumor suppressor protein p53 is emerging as a central regulator of homologous recombination (HR) processes and DNA replication. P53 may downregulate HR through multiple mechanisms including the reported associations with the Rad51 and Rad54 recombinases, and the BLM and WRN helicases. Here, we investigated whether the interaction of p53 with human replication protein A (RPA) is necessary for the regulation of HR. By employing a plasmid-based HR assay in p53-null H1299 lung carcinoma cells, we studied the HR-suppressing properties of a panel of p53 mutants, which varied in their ability to interact with RPA. Both wild-type p53 and a transactivation-deficient p53 mutant (L22Q/W23S) suppressed HR and prevented RPA binding to ssDNA in vitro and in vivo. Conversely, p53 mutations that specifically disrupt the RPA-binding domain, while not compromising p53 transactivation function (D48H/D49H and W53S/F54S), did not affect HR. Suppression of HR was also not seen with missense mutations in the p53 core domain (His175 and His273), which retained the ability to interact with RPA, suggesting that the disruption of additional binding interactions of p53, for example, with Rad51 or recombination intermediates, also impacts on HR. We hypothesize that sequestration of RPA by p53 at the sites of recombination is one means by which p53 can inhibit HR processes. Our data support and extend the previously formulated 'dual model' of p53's role as guardian of the genome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, p53 has been implicated in other nuclear functions, such as regulating homologous recombination and microRNA processing (Romanova et al., 2004; Suzuki et al., 2009), as well as in several cytoplasmic processes.”
From p53 at a glance (2010) · cites this paper as Romanova et al., 2004
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
p53 accumulates but is functionally impaired when DNA synthesis is blocked
Gottifredi, V., Shieh, S.-Y., Taya, Y., & Prives, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1036 · Cited by 147
Research works printed but not linked: 64
- Abramova NA, Russell J, Botchan M and Li R . (1997). Proc. Natl. Acad. Sci. USA, 94, 7186–7191. · DOI
- Akyüz N, Boehden GS, Süsse S, Rimek A, Preuss U, Scheidtmann KH and Wiesmüller L . (2002). Mol. Cell. Biol., 22, 6306–6317. · DOI · Paper page
- Alberts B . (2003). Nature, 421, 431–435. · DOI · Paper page
- Albrechtsen N, Dornreiter I, Grosse F, Kim E, Wiesmuller L and Deppert W . (1999). Oncogene, 18, 7706–7717. · DOI · Paper page
- Bae SH, Bae KH, Kim JA and Seo YS . (2001). Nature, 412, 456–461. · DOI · Paper page
- Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T and Lopez BS . (1997). Oncogene, 14, 1117–1122. · DOI
- Bishop AJ and Schiestl RH . (2003). Exp. Mol. Pathol., 74, 94–105. · DOI
- Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T and Neckers L . (1998). J. Biol. Chem., 273, 11995–11998. · DOI · Paper page
- Bochkarev A, Pfuetzner RA, Edwards AM and Frappier L . (1997). Nature, 385, 176–181. · DOI · Paper page
- Bochkareva E, Frappier L, Edwards AM and Bochkarev A . (1998). J. Biol. Chem., 273, 3932–3936. · DOI
- Boehden GS, Akyüz N, Roemer K and Wiesmüller L . (2003). Oncogene, 22, 4111–4117. · DOI
- Braun KA, Lao Y, He Z, Ingles CJ and Wold MS . (1997). Biochemistry, 36, 8443–8454. · DOI
- Brush GS, Anderson CW and Kelly TJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 12520–12524. · DOI · Paper page
- Buchhop S, Gibson MK, Wang XW, Wagner P, Sturzbecher HW and Harris CC . (1997). Nucleic Acids Res., 25, 3868–3874. · DOI · Paper page
- Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD and Berger SL . (1997). Oncogene, 15, 807–816. · DOI · Paper page
- Carbone R, Pearson M, Minucci S and Pelicci PG . (2002). Oncogene, 21, 1633–1640. · DOI · Paper page
- Dronkert ML and Kanaar R . (2001). Mutation Res., 486, 217–247. · DOI · Paper page
- Dudenhöffer C, Kurth M, Janus F, Deppert W and Wiesmüller L . (1999). Oncogene, 18, 5773–5784. · DOI
- Dudenhöffer C, Rohaly G, Will K, Deppert W and Wiesmüller L . (1998). Mol. Cell. Biol., 18, 5332–5342. · DOI
- Dutta A, Ruppert JM, Aster JC and Winchester E . (1993). Nature, 365, 79–82. · DOI · Paper page
- Gebow D, Miselis N and Liber HL . (2000). Mol. Cell. Biol., 20, 4028–4035. · DOI
- Halazonetis TD, Davis LJ and Kandil AN . (1993). EMBO J., 12, 1021–1028. · DOI · Paper page
- Henricksen LA, Umbricht CB and Wold MS . (1994). J. Biol. Chem., 269, 11121–11132. · DOI · Paper page
- Holmes AM and Haber JE . (1999). Cell, 96, 415–424. · DOI · Paper page
- Huang P . (1998). Oncogene, 17, 261–270. · DOI
- Hupp TR, Meek DW, Midgley CA and Lane DP . (1992). Cell, 71, 875–886. · DOI · Paper page
- Iftode C, Daniely Y and Borowiec JA . (1999). Crit. Rev. Biochem. Mol. Biol., 34, 141–180. · DOI · Paper page
- Janus F, Albrechtsen N, Knippschild U, Wiesmüller L, Grosse F and Deppert W . (1999). Mol. Cell. Biol., 19, 2155–2168. · DOI
- Janz C and Wiesmüller L . (2002). Oncogene, 21, 5929–5933. · DOI
- Kass-Eisler A and Greider CW . (2000). Trends Biochem. Sci., 25, 200–204. · DOI
- Kim C, Snyder RO and Wold MS . (1992). Mol. Cell. Biol., 12, 3050–3059. · doi:10.1128/mcb.12.7.3050-3059.1992 · Paper page
- Lao Y, Lee CG and Wold MS . (1999). Biochemistry, 38, 3974–3984. · DOI
- Lee S, Cavallo L and Griffith J . (1997). J. Biol. Chem., 272, 7532–7539. · DOI
- Levine AJ . (1997). Cell, 88, 323–331. · DOI · Paper page
- Lin YL, Chen C, Keshav KF, Winchester E and Dutta A . (1996). J. Biol. Chem., 271, 17190–17198. · DOI
- Liu JS, Kuo SR, McHugh MM, Beerman TA and Melendy T . (2000). J. Biol. Chem., 275, 1391–1397. · DOI
- Martinez J, Georgoff I and Levine AJ . (1991). Genes Dev., 5, 151–159. · DOI · Paper page
- Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS and Powell SN . (1997). Oncogene, 14, 1847–1857. · DOI · Paper page
- Mummenbrauer T, Janus F, Muller B, Wiesmüller L, Deppert W and Grosse F . (1996). Cell, 85, 1089–1099. · DOI · Paper page
- Park MS, Ludwig DL, Stigger E and Lee SH . (1996). J. Biol. Chem., 271, 18996–19000. · DOI · Paper page
- Philipova D, Mullen JR, Maniar HS, Lu J, Gu C and Brill SJ . (1996). Genes Dev., 10, 2222–2233. · DOI
- Prives C, Bargonetti J, Farmer G, Ferrari E, Friedlander P, Wang Y, Jayaraman L, Pavletich N and Hubscher U . (1994). Cold Spring Harbor Sympos. Quantitat. Biol., 59, 207–213. · DOI
- Romanova LY, Alexandrov IA, Blagosklonny MV, Nordan RP, Garfield S, Acs P, Nguyen P, Trepel J, Blumberg PM and Mushinski JF . (1999). J. Cell. Physiol., 179, 157–169. · doi:10.1002/(sici)1097-4652(199905)179:2<157::aid-jcp6>3.0.co;2-4
- Saintigny Y and Lopez BS . (2002). Oncogene, 21, 488–492. · DOI
- Saintigny Y, Rouillard D, Chaput B, Soussi T and Lopez BS . (1999). Oncogene, 18, 3553–3563. · DOI
- Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, Valerie K, Shay JW, Ellis NA, Wasylyk B and Harris CC . (2003). EMBO J., 22, 1210–1222. · DOI · Paper page
- Sigurdsson S, Trujillo K, Song B, Stratton S and Sung P . (2001). J. Biol. Chem., 276, 8798–8806. · DOI · Paper page
- Sionov RV and Haupt Y . (1999). Oncogene, 18, 6145–6157. · DOI · Paper page
- Stillman BW and Gluzman Y . (1985). Mol. Cell. Biol., 5, 2051–2060. · DOI · Paper page
- Stürzbecher HW, Donzelmann B, Henning W, Knippschild U and Buchhop S . (1996). EMBO J., 15, 1992–2002. · DOI · Paper page
- Süsse S, Janz C, Janus F, Deppert W and Wiesmüller L . (2000). Oncogene, 19, 4500–4512. · DOI
- Thompson LH and Schild D . (2001). Mutat. Res., 477, 131–153. · DOI · Paper page
- Treuner K, Eckerich C and Knippers R . (1998). J. Biol. Chem., 273, 31744–31750. · DOI
- Walther AP, Bjerke MP and Wold MS . (1999). Nucleic Acids Res., 27, 656–664. · DOI
- Wiesmüller L, Cammenga J and Deppert W . (1996). J. Virol., 70, 737–744. · DOI
- Wilcock D and Lane DP . (1991). Nature, 349, 429–431. · DOI · Paper page
- Willers H, McCarthy EE, Hubbe P, Dahm-Daphi J and Powell SN . (2001). Carcinogenesis, 22, 1757–1763. · DOI
- Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F and Powell SN . (2000b). Oncogene, 19, 632–639. · DOI
- Willers H, Xia F and Powell SN . (2002). J. Biomed. Biotechnol., 2, 86–93. · DOI
- Xia F, Taghian DG, DeFrank JS, Zeng ZC, Willers H, Iliakis G and Powell SN . (2001). Proc. Natl. Acad. Sci. USA, 98, 8644–8649. · DOI · Paper page
- Yang Q, Zhang R, Wang XW, Spillare EA, Linke SP, Subramanian D, Griffith JD, Li JL, Hickson ID, Shen JC, Loeb LA, Mazur SJ, Appella E, Brosh Jr RM, Karmakar P, Bohr VA and Harris CC . (2002). J. Biol. Chem., 277, 31980–31987. · DOI
- Yuzhakov A, Kelman Z, Hurwitz J and O’Donnell M . (1999). EMBO J., 18, 6189–6199. · DOI · Paper page
- Zhou J and Prives C . (2003). Nucleic Acids Res., 31, 3881–3892. · DOI
- Zink D, Mayr C, Janz C and Wiesmüller L . (2002). Oncogene, 21, 4788–4800. · DOI
Cited by
Regulation of DNA double-strand break repair pathway choice
Shrivastav, M., De Haro, L. P., & Nickoloff, J. A. (2008) · Cell Research · doi:10.1038/cr.2007.111 · Cited by 1,329
p53 in the DNA–Damage–Repair Process
Williams, A. B., & Schumacher, B. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026070 · Cited by 835
Brady, C. A., & Attardi, L. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.064501 · Cited by 403
Chan, N., Koritzinsky, M., Zhao, H., Bindra, R., Glazer, P. M., Powell, S., Belmaaza, A., Wouters, B., & Bristow, R. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5472 · Cited by 328
Self-citationp53 modulation of the DNA damage response
Helton, E. S., & Chen, X. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21091 · Cited by 293
Metadata
- Authors
- Romanova, L. Y., Willers, H., Blagosklonny, M. V., & Powell, S. N.
- Venue
- Oncogene
- Published
- 2004-10-18
- Volume
- 23
- Issue
- 56
- Pages
- 9025-9033
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 95
- References
- 3
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.